A medical prescription is required in order to carry out the tests. As these are Nuclear Medicine procedures, the scans involve the administration of a very low-dose radioactive drug, which is eliminated over the following hours via the urinary or digestive tract. Before any scan, the procedure will be explained to you and you will be given a specific information sheet. If you are a woman and are pregnant, think you may be pregnant, or are breastfeeding, please inform the healthcare staff before the scan. Patients under 18 or those requiring special care must always be accompanied.
Available procedures
- NEUMO-01 Right-to-left shunt scintigraphy
- NEUMO-02 Lung scintigraphy with ⁶⁷Ga
- NEUMO-03 Lung tomoscintigraphy (SPECT/SPECT-CT) with ⁶⁷Ga
- NEUMO-04 Lung perfusion scintigraphy
- NEUMO-05 Lung ventilation scintigraphy
- NEUMO-06 Lung somatostatin receptor scintigraphy (¹¹¹In-octreotide)
- NEUMO-07 Scintigraphy/SPECT-CT with ¹¹¹In-octreotide
- NEUMO-08 Somatostatin receptor whole-body scan
- NEUMO-09 Lung somatostatin receptor tomography (SPECT/SPECT-CT)
- NEUMO-10 Lung ventilation/perfusion tomoscintigraphy (SPECT/SPECT-CT)
NEUMO-01
Right-to-left shunt scintigraphy
Description: Study of right-to-left shunts.
Preparation
- No prior preparation is required.
Indications
- Assessment of right-to-left shunts by means of a whole-body scan with MAA.
Test duration
15 minutes.
NEUMO-02 · 03
Lung scintigraphy with ⁶⁷Ga / Lung tomoscintigraphy (SPECT/SPECT-CT) with ⁶⁷Ga
Description: Assessment of inflammatory and infectious activity in the lungs.
Preparation
- No prior preparation is required.
- No fasting required.
- The patient must return after 48 hours for image acquisition.
Indications
- Diagnosis and localisation of lung infections.
- Assessment of interstitial lung diseases (specifically sarcoidosis and fibrosis).
- Assessment of patients with AIDS.
Test duration
2 days.
NEUMO-04
Lung perfusion scintigraphy
Description: Quantification and assessment of the distribution of regional pulmonary blood flow.
Preparation
- No prior preparation is required.
- No fasting required.
Indications
- Diagnosis of pulmonary thromboembolism (PE).
- Study of regional lung perfusion.
- Quantification of bilateral and regional lung perfusion.
- Quantification of right-to-left shunts.
- Quantification of secondary systemic shunting in pulmonary arteriovenous fistulas or right-to-left cardiac shunts.
- Pre-operative assessment in lung cancer, transplantation, etc.
Test duration
20 minutes.
NEUMO-05
Lung ventilation scintigraphy
Description: Assessment and quantification of regional lung ventilation.
Preparation
- No prior preparation is required.
- No fasting required.
- It cannot be performed in patients on assisted ventilation.
Indications
- Diagnosis of pulmonary thromboembolism (PE).
- Study of obstructive lung disease, chronic obstructive bronchopneumopathy, COPD, emphysema, bullae and bronchiectasis.
- Assessment of regional lung ventilation.
- If quantified: pre-operative assessment in lung cancer, transplantation, etc.
Test duration
30 minutes.
NEUMO-06 · 07 · 08 · 09
Lung somatostatin receptor scintigraphy (¹¹¹In-octreotide) / Scintigraphy/SPECT-CT with ¹¹¹In-octreotide / Somatostatin receptor whole-body scan / Lung somatostatin receptor tomography (SPECT/SPECT-CT)
Description: Assessment of somatostatin receptor activity in lung tumours.
Preparation
- No prior preparation is required.
- The patient will remain fasting during the test.
- No examinations with barium or iodinated contrast should be performed for the duration of the test.
Indications
- Assessment of tumours expressing somatostatin receptors (staging, follow-up, monitoring of therapeutic response and detection of recurrence): neuroendocrine tumours, such as carcinoid, lung cancer, etc.
Test duration
2 days.
NEUMO-10
Lung ventilation/perfusion tomoscintigraphy (SPECT/SPECT-CT)
Description: Tomographic assessment of lung perfusion and ventilation.
Preparation
- No prior preparation is required.
- No fasting required.
Indications
- Diagnosis of pulmonary thromboembolism (PE).
- Study of obstructive lung disease, chronic obstructive bronchopneumopathy, COPD, emphysema, bullae and bronchiectasis.
- Assessment of regional lung perfusion and ventilation.
- Pre-operative assessment in lung cancer, transplantation, etc.
Test duration
40 minutes.